A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response

Introduction We report a rare case of marked rectal stenosis due to Douglas' pouch metastasis of renal pelvic urothelial carcinoma successfully treated with enfortumab vedotin. Case presentation A 77‐year‐old female presented with difficulty in defecation and abdominal distension. She had recei...

Full description

Bibliographic Details
Main Authors: Jun Akatsuka, Go Kimura, Akifumi Katsu, Hiroya Hasegawa, Hikaru Mikami, Masato Yanagi, Yuki Endo, Hayato Takeda, Yuka Toyama, Yukihiro Kondo
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:IJU Case Reports
Subjects:
Online Access:https://doi.org/10.1002/iju5.12645
_version_ 1827762360267309056
author Jun Akatsuka
Go Kimura
Akifumi Katsu
Hiroya Hasegawa
Hikaru Mikami
Masato Yanagi
Yuki Endo
Hayato Takeda
Yuka Toyama
Yukihiro Kondo
author_facet Jun Akatsuka
Go Kimura
Akifumi Katsu
Hiroya Hasegawa
Hikaru Mikami
Masato Yanagi
Yuki Endo
Hayato Takeda
Yuka Toyama
Yukihiro Kondo
author_sort Jun Akatsuka
collection DOAJ
description Introduction We report a rare case of marked rectal stenosis due to Douglas' pouch metastasis of renal pelvic urothelial carcinoma successfully treated with enfortumab vedotin. Case presentation A 77‐year‐old female presented with difficulty in defecation and abdominal distension. She had received two courses of cisplatin plus gemcitabine followed by four courses of maintenance avelumab for postoperative lymph node metastasis of renal pelvic urothelial carcinoma. KL‐6 levels were elevated, and a computed tomography scan revealed an irregularly shaped large mass occupying Douglas' pouch, with marked rectal stenosis. Metastatic urothelial carcinoma was pathologically diagnosed, and enfortumab vedotin was initiated after colostomy. After 12 courses of enfortumab vedotin, metastatic lesions showed marked shrinkage and KL‐6 levels decreased. Conclusion Enfortumab vedotin elicited a remarkable response in treating rectal stenosis due to metastasis of renal pelvic urothelial carcinoma in Douglas' pouch. Furthermore, serum KL‐6 levels were correlated with the severity of metastatic urothelial carcinoma.
first_indexed 2024-03-11T10:28:31Z
format Article
id doaj.art-51d17c72a77345a29a4b65d034b78846
institution Directory Open Access Journal
issn 2577-171X
language English
last_indexed 2024-03-11T10:28:31Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series IJU Case Reports
spelling doaj.art-51d17c72a77345a29a4b65d034b788462023-11-15T06:01:08ZengWileyIJU Case Reports2577-171X2023-11-016644945310.1002/iju5.12645A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor responseJun Akatsuka0Go Kimura1Akifumi Katsu2Hiroya Hasegawa3Hikaru Mikami4Masato Yanagi5Yuki Endo6Hayato Takeda7Yuka Toyama8Yukihiro Kondo9Department of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanDepartment of Urology Nippon Medical School Tokyo JapanIntroduction We report a rare case of marked rectal stenosis due to Douglas' pouch metastasis of renal pelvic urothelial carcinoma successfully treated with enfortumab vedotin. Case presentation A 77‐year‐old female presented with difficulty in defecation and abdominal distension. She had received two courses of cisplatin plus gemcitabine followed by four courses of maintenance avelumab for postoperative lymph node metastasis of renal pelvic urothelial carcinoma. KL‐6 levels were elevated, and a computed tomography scan revealed an irregularly shaped large mass occupying Douglas' pouch, with marked rectal stenosis. Metastatic urothelial carcinoma was pathologically diagnosed, and enfortumab vedotin was initiated after colostomy. After 12 courses of enfortumab vedotin, metastatic lesions showed marked shrinkage and KL‐6 levels decreased. Conclusion Enfortumab vedotin elicited a remarkable response in treating rectal stenosis due to metastasis of renal pelvic urothelial carcinoma in Douglas' pouch. Furthermore, serum KL‐6 levels were correlated with the severity of metastatic urothelial carcinoma.https://doi.org/10.1002/iju5.12645biomarkerKL‐6rectal stenosisrenal pelvic urothelial carcinoma
spellingShingle Jun Akatsuka
Go Kimura
Akifumi Katsu
Hiroya Hasegawa
Hikaru Mikami
Masato Yanagi
Yuki Endo
Hayato Takeda
Yuka Toyama
Yukihiro Kondo
A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
IJU Case Reports
biomarker
KL‐6
rectal stenosis
renal pelvic urothelial carcinoma
title A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
title_full A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
title_fullStr A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
title_full_unstemmed A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
title_short A case of marked rectal stenosis due to Douglas’ pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin: correlation between serum KL‐6 levels and tumor response
title_sort case of marked rectal stenosis due to douglas pouch metastasis of renal pelvic carcinoma successfully treated with salvage enfortumab vedotin correlation between serum kl 6 levels and tumor response
topic biomarker
KL‐6
rectal stenosis
renal pelvic urothelial carcinoma
url https://doi.org/10.1002/iju5.12645
work_keys_str_mv AT junakatsuka acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT gokimura acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT akifumikatsu acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hiroyahasegawa acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hikarumikami acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT masatoyanagi acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukiendo acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hayatotakeda acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukatoyama acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukihirokondo acaseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT junakatsuka caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT gokimura caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT akifumikatsu caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hiroyahasegawa caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hikarumikami caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT masatoyanagi caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukiendo caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT hayatotakeda caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukatoyama caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse
AT yukihirokondo caseofmarkedrectalstenosisduetodouglaspouchmetastasisofrenalpelviccarcinomasuccessfullytreatedwithsalvageenfortumabvedotincorrelationbetweenserumkl6levelsandtumorresponse